Op-ed: Gottlieb says A.I. may take on doctors' roles sooner than later
Dr. Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing startup Tempus, health-care tech company Aetion Inc. and biotech company Illumina. He is also a partner at the venture capital firm New Enterprise Associates Researchers at Harvard presented a study…
#scottgottlieb #pfizer #aetioninc #illumina #harvard #chatgpt #amazon #healthscribe #googlebrainai #fda